The DOI matches its Crossref record; 192 of the 198 references it cites were found in a registry or an index.
Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Open accessAbstract
homeostasis, autophagy, the release of nitric oxide and inflammatory mediators and altered gene and protein expression that involved apoptosis. Dox also causes downregulation of DNA methyltransferase 1 (DNMT1) enzyme activity which leads to a reduction in the DNA methylation process. This hypomethylation causes dysregulation in the mitochondrial genes like peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1-alpha (PGC-1α), nuclear respiratory factor 1 (NRF-1) and mitochondrial transcription factor A (TFAM) unit in the heart. Apart from DNA methylation, Dox treatment also alters the micro RNAs levels and histone deacetylase (HDAC) activity. Therefore, in the current review, we have provided a detailed update on the current understanding of the pathological mechanisms behind the well-known Dox-induced cardiotoxicity. Further, we have provided some of the most plausible pharmacological strategies which have been tested against Dox-induced cardiotoxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The cumulative anthracycline dose is a major risk factor for severe cardiomyopathy development but young age at treatment, female sex, peak drug exposure and additional stress to the heart have also been implicated 161,162,163 .”
From Osteosarcoma (2022) · cites this paper as [163]
Citations
Cites
2 retracted
Suliman, H. B., Carraway, M. S., Ali, A. S., Reynolds, C. M., Welty‐Wolf, K. E., & Piantadosi, C. A. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32967 · Cited by 261
RetractedChoi, H. C., Song, P., Xie, Z., Wu, Y., Xu, J., Zhang, M., Dong, Y., Wang, S., Lau, K., & Zou, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803020200 · Cited by 85
RetractedAn integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,868
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039
The ENCODE (ENCyclopedia Of DNA Elements) Project
(2004) · Science · doi:10.1126/science.1105136 · Cited by 2,390
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells
Lister, R., Pelizzola, M., Kida, Y. S., Hawkins, R. D., Nery, J. R., Hon, G. C., Antosiewicz‐Bourget, J., O’Malley, R. C., Castanon, R., Klugman, S. A., et al. (2011) · Nature · doi:10.1038/nature09798 · Cited by 1,595
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S. P., Crijns, H. J. G. M., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,425
Nitric Oxide Synthases: Properties and Catalytic Mechanism
Griffith, O. W., & Stuehr, D. J. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.003423 · Cited by 1,311
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Ichikawa, Y., Ghanefar, M., Bayeva, M., Wu, R., Khechaduri, A., Prasad, S. V. N., Mutharasan, R. K., Naik, T. J., & Ardehali, H. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72931 · Cited by 881
Research works printed but not linked: 6
- Gianni, 2008, Anthracycline cardiotoxicity: from bench to bedside, J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol., 26, 3777, 10.1200/JCO.2007.14.9401 · DOI
- Chustecka, 2006, Cardiotoxicity of imatinib is a" surprise, Nat. Med., 24
- Martínez-Mateo, 2017, Report of cisplatin-induced cardiotoxicity: a side effect to monitor closely, J. Heart Health, 3
- Speth, 1988, Clinical pharmacokinetics of doxorubicin, Clin. Pharmacokinet., 15, 15, 10.2165/00003088-198815010-00002 · DOI
- Youngson, 2006, Collins dictionary of human biology, Collins
- Zhu, 2009, Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mTOR pathway, Circulation, 119, 99, 10.1161/CIRCULATIONAHA.108.799700 · DOI
Cited by
Sorted by citations
Items 101–200 of 915
Bews, H. J., Mackic, L., & Jassal, D. S. (2023) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2023-0358 · Cited by 31
Yu, B., Liu, M., Jiang, L., Xu, C., Hu, H., Huang, T., Xu, D., Wang, N., Li, Q., Tang, B. Z., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202303643 · Cited by 31
Maneechote, C., Khuanjing, T., Ongnok, B., Arinno, A., Prathumsap, N., Chunchai, T., Arunsak, B., Nawara, W., Chattipakorn, S. C., & Chattipakorn, N. (2022) · Clinical Science · doi:10.1042/cs20220074 · Cited by 31
Simvastatin Reduces Doxorubicin-Induced Cardiotoxicity: Effects beyond Its Antioxidant Activity
Pecoraro, M., Marzocco, S., Belvedere, R., Petrella, A., Franceschelli, S., & Popolo, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087573 · Cited by 30
Wei, S., Ma, W., Jiang, C., Liu, J., Liu, J., Zhang, B., & Li, W. (2023) · Phytotherapy Research · doi:10.1002/ptr.7900 · Cited by 30
Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods
Kuang, Z., Kong, M., Yan, N., Ma, X., Wu, M., & Li, J. P. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01203-6 · Cited by 30
Chen, L., Chen, X., Ruan, B., Yang, H., & Yu, Y. (2024) · Peptides · doi:10.1016/j.peptides.2024.171245 · Cited by 30
Chen, J., Qiu, S., Liu, Y., Sun, W., Zhou, T., Zhao, L., Li, Z., & Duan, Y. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02794-w · Cited by 30
Effective breast cancer therapy based on palmitic acid-loaded PLGA nanoparticles
He, Y., Júnior, R. F. D. A., Cavalcante, R. S., Yu, Z., Schomann, T., Gu, Z., Eich, C., & Cruz, L. J. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.213270 · Cited by 30
Shochah, Q. R., & Jabir, F. A. (2023) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-022-03697-2 · Cited by 30
Zhang, L., Jiang, Q., Wang, X., Jaisi, A., & Olatunji, O. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-38560-5 · Cited by 29
Mostafa, M. A. H., & Khojah, H. M. J. (2025) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2025.2483425 · Cited by 33
Zhou, L., Han, Y., Yang, Q., Xin, B., Chi, M., Huo, Y., Guo, C., & Sun, X. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105366 · Cited by 29
Patil, P. P., Khanal, P., Patil, V. S., Charla, R., Harish, D. R., Patil, B. M., & Roy, S. (2022) · Antioxidants · doi:10.3390/antiox11061094 · Cited by 29
Al-Kuraishy, H. M., Al-Gareeb, A. I., ALKHURIJI, A. F., Al‐Megrin, W. A. I., Elekhnawy, E., Negm, W. A., WAARD, M. M. D., & Batiha, G. E. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113673 · Cited by 29
Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Bo, Y., Zhao, X., & Li, L. (2024) · Clinical Science · doi:10.1042/cs20231156 · Cited by 30
The Role of Resveratrol in Cancer Management: From Monotherapy to Combination Regimens
Ribeiro, E., & Vale, N. (2024) · Targets · doi:10.3390/targets2040018 · Cited by 28
Mitigation of doxorubicin-induced cardiotoxicity with an H2O2-Activated, H2S-Donating hybrid prodrug
Hu, Q., Yammani, R. D., Brown, H. M., Soto‐Pantoja, D. R., Poole, L. B., & Lukesh, J. C. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102338 · Cited by 28
Sun, M., Shi, W., Wu, Y., He, Z., Sun, J., Cai, S., & Luo, Q. (2022) · Advanced Science · doi:10.1002/advs.202205247 · Cited by 28
Radeva, L., Yordanov, Y., Spassova, I., Kovacheva, D., Tzankova, V., & Yoncheva, K. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041287 · Cited by 28
Zhang, E., Shang, C., Ma, M., Zhang, X., Liu, Y., Song, S., & Li, X. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121334 · Cited by 28
Evolution of Theories on Doxorubicin-Induced Late Cardiotoxicity-Role of Topoisomerase
Szponar, J., Ciechański, E., Ciechańska, M., Dudka, J., & Mańdziuk, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413567 · Cited by 27
Hydroxytyrosol Prevents Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes
Sirangelo, I., Liccardo, M., & Iannuzzi, C. (2022) · Antioxidants · doi:10.3390/antiox11061087 · Cited by 27
Santin, Y., Formoso, K., Haidar, F., Fuentes, M. D. P. O., Bourgailh, F., Hifdi, N., Hnia, K., Doghri, Y., Resta, J., Champigny, C., et al. (2023) · Theranostics · doi:10.7150/thno.86310 · Cited by 27
Wang, L., Liu, Y., Li, S., Zha, Z., Chen, Y., Wang, Q., Zhou, S., Huang, X., & Xu, M. (2023) · Aging · doi:10.18632/aging.205138 · Cited by 27
Zou, H., Zhang, M., Yang, X., Shou, H., Chen, Z., Zhu, Q., Luo, T., Mou, X., & Chen, X. (2024) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2300691 · Cited by 26
Research progress on the molecular mechanisms of Saikosaponin D in various diseases (Review)
Gu, S., Zheng, Y., Chen, C., Liu, J., Wang, Y., Wang, J., & Li, Y. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5478 · Cited by 27
Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity By Activating the Nrf2 Pathway
Hu, X., Li, C., Wang, Q., Wei, Z., Chen, T.-Z., Wang, Y., & Li, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.872057 · Cited by 27
Yi, X., Wang, F., Feng, Y., Zhu, J., & Wu, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.929302 · Cited by 26
Okpara, E. S., Adedara, I. A., Guo, X., Klos, M., Farombi, E. O., & Han, S. (2022) · Toxicology Reports · doi:10.1016/j.toxrep.2022.09.001 · Cited by 27
Singh, S. K., Yadav, P., Patel, D., Tanwar, S. S., Sherawat, A., Khurana, A., Bhatti, J. S., & Navik, U. (2024) · Environmental Toxicology · doi:10.1002/tox.24291 · Cited by 25
Self-citationYang, D., Chen, Y., Chen, Y.-K., Zeng, Y.-L., & Ling, Z. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf033 · Cited by 26
Assali, M., Jaradat, N. A., & Maqboul, L. (2022) · ACS Omega · doi:10.1021/acsomega.2c04238 · Cited by 25
Misiak, P., Niemirowicz-Laskowska, K., Markiewicz, K. H., Wielgat, P., Kurowska, I., Czarnomysy, R., Misztalewska‐Turkowicz, I., Car, H., Bielawski, K., & Wilczewska, A. Z. (2023) · Cancer Nanotechnology · doi:10.1186/s12645-023-00176-9 · Cited by 25
Zhao, M., Zheng, Z., Pan, W. D., Zhang, J., Yin, Z., Cheng, W., Xu, Y. Q., Wan, J., & Wang, M. (2023) · The FASEB Journal · doi:10.1096/fj.202202079rr · Cited by 26
Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation
Ibrahim, A. A., Nsairat, H., Al-Sulaibi, M., El‐Tanani, M., Jaber, A. M., Lafi, Z. M., Barakat, R., Abuarqoub, D. A., Mahmoud, I. S., Obare, S. O., et al. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2343882 · Cited by 25
Potential role of endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity-an update
Sun, M., Zhang, X., Tan, B., Zhang, Q., Zhao, X., & Dong, D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1415108 · Cited by 24
Role of ferroptosis in the pathogenesis of heart disease
Fatima, S., Zhou, H., Chen, Y., & Liu, Q. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1450656 · Cited by 26
Metrnl as a secreted protein: Discovery and cardiovascular research
Miao, Z., Chen, J., Chen, C.-X., Zheng, S., Zhao, H., & Miao, C. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108730 · Cited by 24
BRD4770 protects against DOX-induced cardiotoxicity by inhibiting apoptosis and ferroptosis
Shao, J., Xiao, R., Wang, T., Wang, F., Wang, B., Zhang, D., Wang, L., Li, J., Liu, J., & Zuo, S. (2025) · Science Advances · doi:10.1126/sciadv.adw1720 · Cited by 24
Shi, H., Yan, Y., Yang, H., Pu, P., & Tang, H. Y. (2022) · BioMed Research International · doi:10.1155/2022/5623555 · Cited by 24
Nisa, F. Y., Rahman, M. A., Rafi, M. K. J., Khan, M. A. N., Sultana, F., Majid, M., Hossain, M. A., Deen, J. I., Mannan, M., Saha, S., et al. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213291 · Cited by 24
Jazani, A. M., Arabzadeh, A., Haghi‐Aminjan, H., & Azgomi, R. N. D. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1022360 · Cited by 24
Qi, Y., Yao, L., Liu, J., & Wang, W. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-03642-7 · Cited by 24
Thonusin, C., Nawara, W., Arinno, A., Khuanjing, T., Prathumsup, N., Ongnok, B., Chattipakorn, S. C., & Chattipakorn, N. (2023) · Journal of Pineal Research · doi:10.1111/jpi.12884 · Cited by 24
Syamprasad, N. P., Jain, S., Rajdev, B., Panda, S. R., Gangasani, J. K., Challa, V. S., Vaidya, J. R., Kundu, G. C., & Naidu, V. G. M. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110566 · Cited by 24
Elhemiely, A. A., El‐Fayoumi, S. H., Gadelmawla, M. H. A., Mahran, N. A., & Gad, A. M. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70465 · Cited by 23
Lin, S. J., Huang, J., Zeng, H., Tong, Q., Zhang, X., Yang, B., Ye, Y., Wang, J., Hu, Z., & Zhang, Y. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.03.064 · Cited by 23
Ilayaperumal, P., Chelladurai, P., Vairan, K., Anilkumar, P., & Balagurusamy, B. (2023) · Macromolecular Materials and Engineering · doi:10.1002/mame.202200553 · Cited by 24
Cao, C., Li, Y., Shi, F., Jiang, S., Li, Y., Yang, L., Zhou, X., Gao, Y., Tang, F., Li, H., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124424 · Cited by 23
Injectable pH-responsive polypeptide hydrogels for local delivery of doxorubicin
Guo, Y., Chen, Y., Wu, Y., Zhu, Y., Luo, S., Shen, J., & Luo, Y. (2024) · Nanoscale Advances · doi:10.1039/d4na00719k · Cited by 22
Soukar, J., Singh, K. A., Aviles, A., Hargett, S. E., Kaur, H. P., Foster, S., Roy, S., Zhao, F., Gohil, V. M., Singh, I., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2505237122 · Cited by 22
Ebrahim, N., AlSaihati, H., Mostafa, O., Hassouna, A., Abdulsamea, S. E., Gebaly, E. A. E. A. M. E., Aborayah, N. H., Sabry, D., El‐Sherbiny, M., Madboly, A. G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115967 · Cited by 22
Al‐Salam, S., Karthishwaran, K., Sudhadevi, M., Yasin, J., & Tariq, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012479 · Cited by 22
Lv, X., Wen, R.-Q., Liu, K., Zhao, X., Pan, C., Gao, X., Wu, X. S., Zhi, X., Ren, C., Chen, Q., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1047700 · Cited by 22
Zhang, M.-W., Li, X., Zhang, Z.-Z., Liu, Y., Song, J.-W., Liu, X., Chen, Y.-H., Wang, N., Guo, Y., Liang, L., et al. (2022) · Cell Stress and Chaperones · doi:10.1007/s12192-022-01317-6 · Cited by 22
Clinical outcomes of chemotherapy in cancer patients with different ethnicities
Pathak, S., Zajac, K. K., Annaji, M., Govindarajulu, M., Nadar, R. M., Bowen, D., Babu, R. J., & Dhanasekaran, M. (2023) · Cancer Reports · doi:10.1002/cnr2.1830 · Cited by 25
Fluorescent Alloyed CdZnSeS/ZnS Nanosensor for Doxorubicin Detection
Mescheryakova, S. A., Matlakhov, I. S., Strokin, P. D., Drozd, D. D., Goryacheva, I. Y., & Goryacheva, O. A. (2023) · Biosensors · doi:10.3390/bios13060596 · Cited by 22
Sunoqrot, S., Abusulieh, S., & Abusara, O. H. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123392 · Cited by 22
Chemical-induced phase transition and global conformational reorganization of chromatin
Wang, T., Shi, S., Shi, Y., Jiang, P., Hu, G., Ye, Q., Shi, Z., Yu, K., Wang, C., Fan, G., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41340-4 · Cited by 22
Ou, D., Yan, H., & Chen, Z. (2024) · Microchimica Acta · doi:10.1007/s00604-024-06176-9 · Cited by 23
Wang, S., Wang, L., Cheng, H., Li, H., Zhang, Q., He, C., Fu, C., & Wei, Q. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102818 · Cited by 22
Dantas, D., Pereira, A. G., Fujimori, A. S. S., Ribeiro, A. P. D., Silva, C. C. V. D. A., Monte, M. G., Corrêa, C. R., Fernandes, A. A. H., Bazan, S. G. Z., Azevedo, P. S., et al. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9080254 · Cited by 21
RGS11-CaMKII complex mediated redox control attenuates chemotherapy-induced cardiac fibrosis
Das, K., Basak, M., Mahata, T., Kumar, M., Kumar, D., Biswas, S., Chatterjee, S., Moniruzzaman, M., Saha, N. C., Mondal, K., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102487 · Cited by 21
Elmorsi, R. M., Saadany, A. A. E., Kabel, A. M., & El-Seoud, S. H. (2023) · Human & Experimental Toxicology · doi:10.1177/09603271231198624 · Cited by 21
Meeran, M. F. N., Arunachalam, S., Azimullah, S., Saraswathiamma, D., Albawardi, A. S., Almarzooqi, S. S., Jha, N. K., Subramanya, S. B., Beiram, R., & Ojha, S. K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814013 · Cited by 21
The protective role of ginsenoside Rg3 in heart diseases and mental disorders
Shi, L.-L., Luo, J.-L., Wei, X.-P., Xu, X., & Tu, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1327033 · Cited by 19
Xue, S., Chen, H., Zhang, J., Tian, R., Xie, C., Sun, Q., Wang, H., Shi, T., Guo, D., Wang, Q., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118604 · Cited by 21
Nirgude, S., Desai, S. S., Mahadeva, R., Ravindran, F., & Choudhary, B. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.835027 · Cited by 21
Wang, X., Ma, C., Mi, K., Cao, X., Tan, Y., Yuan, H., Ren, J. T., & Liang, X. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111363 · Cited by 20
Jackson, K. L., Yin, N., Agafonov, R. V., Chaturvedi, P., Cole, K. S., Eron, S. J., Good, A. C., Hart, J. A., He, M., Henderson, C. S., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01317 · Cited by 22
Doxorubicin induced cardio toxicity through sirtuins mediated mitochondrial disruption
Ahmad, N., Ullah, A., Chu, P., Tian, W., Tang, Z., & Sun, Z. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110028 · Cited by 20
Cardiotoxicity linked to anticancer agents and cardioprotective strategy
Khairnar, S. I., Kulkarni, Y. A., & Singh, K. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01411-4 · Cited by 20
Reaching new lights: a review on photo-controlled nanomedicines and their in vivo evaluation
Remmers, R. C. P. A., & Neumann, K. (2023) · Biomaterials Science · doi:10.1039/d2bm01621d · Cited by 20
Song, J., Kim, M., Lee, S., Hwang, J., Park, S., Park, S. W., Jeon, S., Lee, R.-R., Lee, J., & Choi, H. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155633 · Cited by 20
Kong, L., Liu, Y., Wang, J., Lv, M.-J., Wang, Y.-Z., Sun, W., Cao, H., Guo, R., Zhang, L., Yu, Y., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156529 · Cited by 19
Fmoc-FF Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells
Gallo, E., Smaldone, G., Cimmino, L., Braile, M., Orlandella, F. M., Luciano, N., Accardo, A., & Salvatore, G. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17020263 · Cited by 19
Methylene Blue Mitigates Doxorubicin-Induced Cardiotoxicity via KEAP1/NRF2/GPX-4/Caspase3 Modulation
Ibrahim, S. G., Abu‐Dief, A. M., Gad, A. M., Gad, E. S., Alzahrani, A. Y. A., Alraih, A. M., Barnawi, I. O., Mansour, M., Gadelmawla, M. H. A., & Khames, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167680 · Cited by 19
Understanding the Protective Role of Exosomes in Doxorubicin‐Induced Cardiotoxicity
Zhang, G., Yang, X., Su, X., An, N., Yang, F., Li, X., Jiang, Y., & Xing, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2852251 · Cited by 19
Alkhanjaf, A. A. M., Athar, M. T., Ullah, Z., Alsayhab, A. M. H., Umar, A., & Shaikh, I. A. (2022) · Molecules · doi:10.3390/molecules27238589 · Cited by 19
Burrini, N., D’Ambrosio, M., Gentili, M., Giaquinto, R., Settimelli, V., Luceri, C., Cirri, M., & Francesconi, O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010235 · Cited by 19
A bibliometric analysis of research progress on pharmacovigilance and cancer from 2002 to 2021
Sa, R., Xu, Y., Pan, X., Wang, Y., Lin, Z., Zhang, X., & Zhang, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1078254 · Cited by 21
Hussen, N. H., Hasan, A. H., Muhammed, G. O., Yassin, A. Y., Salih, R. R., Esmail, P. A., Alanazi, M. M., & Jamalis, J. (2023) · Current Organic Chemistry · doi:10.2174/1385272827666230423144150 · Cited by 19
Elmorsy, E. A., Saber, S., Hamad, R. S., Abdel‐Reheim, M. A., El-kott, A. F., AlShehri, M. A., Morsy, K., Negm, S., & Youssef, M. E. (2024) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2024.106849 · Cited by 19
Zhang, J., Zha, Y., Jiao, Y., Li, Y., & Zhang, S. (2023) · Toxicology · doi:10.1016/j.tox.2023.153426 · Cited by 19
Alfreahat, I., Nsairat, H., Al‐Deeb, I., Al-Samydai, A. M., & Alshaer, W. (2025) · Technology in Cancer Research & Treatment · doi:10.1177/15330338241312561 · Cited by 18
Wu, Y., Gao, D., Xue, J., & Zuo, Z. (2022) · Biomolecules · doi:10.3390/biom12121788 · Cited by 18
Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism
Zhao, Y., Jia, H., Hua, X., An, T., & Song, J. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01906-6 · Cited by 19
Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles
Li, K., Chen, W., Ma, L., Yan, L., & Wang, B. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117264 · Cited by 18
Meng, P.-N., Chen, Z., Sun, T., Wu, L., Wang, Y., Guo, T., Yang, J., & Zhu, J. (2023) · Aging · doi:10.18632/aging.205062 · Cited by 18
Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC
Xu, F., Zang, T., Chen, H., Zhou, C., Wang, R., Yu, Y., Shen, L., Qian, J., & Ge, J. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110937 · Cited by 18
Wang, L., Wu, Y., Yang, N., Yin, W., Huang, Y., Li, C., Zhuang, Y., Song, Z., Cheng, X., Shi, S., et al. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128691 · Cited by 18
Dalimunthe, A., Satria, D., Sitorus, P., Harahap, U., Angela, I. F. D., & Waruwu, S. B. (2024) · Pharmaceuticals · doi:10.3390/ph17030359 · Cited by 20
Guerassimoff, L., Ferrere, M., Herck, S. V., Dehissi, S., Nicolas, V., Geest, B. G. D., & Nicolas, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.03.049 · Cited by 18
Novel PLGA-based nanoformulation decreases doxorubicin-induced cardiotoxicity
Drinković, N., Beus, M., Barbir, R., Debeljak, Ž., Lovaković, B. T., Kalčec, N., Ćurlin, M., Bekavac, A., Gorup, D., Mamić, I., et al. (2024) · Nanoscale · doi:10.1039/d3nr06269d · Cited by 18
Therapeutic Effects of Melatonin in the Regulation of Ferroptosis: A Review of Current Evidence
Pourhanifeh, M. H., Hosseinzadeh, A., Koosha, F., Reiter, R. J., & Mehrzadi, S. (2024) · Current Drug Targets · doi:10.2174/0113894501284110240426074746 · Cited by 18
An overview of different methods to establish a murine premature ovarian failure model
Pouladvand, N., Azarnia, M., Zeinali, H., Fathi, R., & Tavana, S. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12477 · Cited by 18
Zobeydi, A. M., Namavar, S. N. M., Shahdani, M. S., Choobineh, S., Kordi, M. R., & Rakhshan, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-91133-6 · Cited by 18
Srikanth, Y., Dontiboina, H. R., Anusha, V. L., Dumala, N., Viswanadh, M. K., Chakravarthi, G., Nalluri, B. N., Yadagiri, G., & Ramakrishna, K. (2025) · Plants · doi:10.3390/plants14050827 · Cited by 17
Unlocking pH-responsive dual payload release through hydrazone linkage chemistry
Abd-Ellah, H. S., Zhao, D., Zhou, Y., & Baell, J. B. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118172 · Cited by 17
Metadata
- Authors
- Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U.
- Affiliations
- Central University of Punjab (IN)
- P.V. Narsimha Rao Telangana Veterinary University (IN)
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 139
- Pages
- 111708
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W3160992829
- Cited by
- 909
- References
- 198
- Citations by year
- 2026: 171 · 2025: 232 · 2024: 208 · 2023: 193 · 2022: 92 · 2021: 13
- FWCI
- 24.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicine & Pharmacotherapy (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Royal Society of Medicine
- University of Central Punjab (GP-25)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- doxorubicin, cardiotoxicity, molecular mechanisms, DNA methylation, DNMT1, mitochondrial dysfunction, PGC-1α, NRF1, TFAM, microRNA, histone deacetylase, autophagy, apoptosis, nitric oxide, inflammatory mediators, cardioprotection, anthracycline chemotherapy
- MeSH terms
- Animals, Antibiotics, Antineoplastic, Doxorubicin, Humans, Mitochondria, Heart, Apoptosis, Oxidative Stress, Cardiotoxicity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review